A patient sits down and asks for “Botox<\/mark><\/a>,” but what she actually wants is smoother crow’s feet and a softer frown line by Friday. Whether that’s delivered with Botox or Bocouture<\/mark><\/a> is a decision that sits with the aesthetic practitioner<\/mark><\/a> and prescriber<\/mark><\/a>, not the patient’s brand recall \u2014 and it’s a decision that should be made on units, reconstitution behaviour and licensing, not on which name is more familiar.<\/p>\n\n\n\n Bocouture Botox comparisons come up constantly in UK clinics because both are botulinum toxin<\/mark><\/a> type A, both are prescription-only medicines, and both are licensed for upper facial lines. But they are not interchangeable vial-for-vial, and treating them as if they are is one of the more common dosing errors newer injectors make. This piece sets out what actually differs, how to handle both products safely, and where to buy authenticated stock.<\/p>\n\n\n\n Botox (onabotulinumtoxinA, manufactured by Allergan\/AbbVie) and Bocouture (incobotulinumtoxinA, manufactured by Merz Aesthetics) both work the same way at a molecular level: they cleave SNAP-25 at the neuromuscular junction, blocking acetylcholine release so the treated muscle can’t contract until new nerve terminals sprout. That’s why the effect is temporary and why both are dosed against muscle bulk and activity rather than skin.<\/p>\n\n\n\n The formulation is where they part ways. Botox is a complex formulation that includes accessory proteins alongside the active toxin. Bocouture is a “naked” formulation, stripped of the complexing proteins that carry no role in the neuromuscular blocking effect but are thought to contribute to antibody formation with repeated, long-term use. Bocouture also doesn’t need refrigeration before reconstitution, which removes a cold-chain concern for clinics running outreach days or working across sites \u2014 Botox does require cold storage.<\/p>\n\n\n\n Genuine current frustration for many practitioners is unit confusion. A unit of Botox is not the same as a unit of Bocouture, Azzalure<\/mark><\/a> or Dysport<\/mark><\/a> \u2014 each manufacturer’s potency assay is proprietary, so doses don’t convert on a simple ratio. The manufacturer’s licensing documentation is explicit that unit doses are not interchangeable between preparations. Comparative studies have generally shown onabotulinumtoxinA and incobotulinumtoxinA performing at close to a 1:1 ratio in practice, which is why many practitioners switch across at similar numbers \u2014 but that’s an observed clinical pattern, not an official conversion, and it shouldn’t be treated as one on the first switch.<\/p>\n\n\n\n Botox is licensed in the UK for the temporary improvement of moderate to severe glabellar lines, and is widely used off-label for forehead lines and lateral canthal lines (crow’s feet) as part of standard upper-face treatment. It also carries licensed indications outside aesthetics, including hyperhidrosis, chronic migraine and overactive bladder \u2014 relevant if a clinic also runs medical toxin lists alongside cosmetic work.<\/p>\n\n\n\n Botox Areas commonly treated in aesthetic practice include the glabella (typically 20 units), the frontalis (10\u201320 units depending on muscle activity and brow position), and the lateral orbicularis oculi for Crows Feet Botox (typically 8\u201312 units per side). Total upper-face treatments commonly fall between 30 and 64 units, which is why vial size selection matters at a business level: a 50-unit vial suits single-patient, single-area work with minimal wastage, while 100-unit and 200-unit vials reduce the per-unit cost for clinics running a full day of combined upper-face treatments or treating larger muscle groups such as masseter.<\/p>\n\n\n\n Caution is needed with Botox Under Eyes, referring to the lower orbicularis oculi and infraorbital area. This zone sits close to the depressor muscles that support the lower eyelid, and over-treatment or diffusion into this area is a recognised cause of lower lid malposition and scleral show. Conservative dosing, precise depth and wide spacing from the inferior orbital rim reduce this risk.<\/p>\n\n\n\n Botox 50 Units, Botox 100 Units and Botox 200 Units are all supplied as a lyophilised powder and must be reconstituted with preservative-free 0.9% sodium chloride before use. Standard practice is to introduce the saline gently down the inside wall of the vial rather than injecting it directly onto the powder, to avoid denaturing the protein through excess agitation or foaming. Dilution volume is a clinical decision, not a convenience choice \u2014 the volume the toxin is reconstituted in affects how far it diffuses from each injection point, which matters most in delicate areas like the periorbital region.<\/p>\n\n\n\nWhat’s Actually Different Between Botox and Bocouture<\/h2>\n\n\n\n
Botox 50 Units, 100 Units and 200 Units: Choosing the Right Vial Size<\/h2>\n\n\n\n
What Botox Is Licensed For<\/h3>\n\n\n\n
Botox Areas and Realistic Unit Ranges<\/h2>\n\n\n\n
Reconstituting Botox<\/h3>\n\n\n\n